Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Greasley, R.U., Turner, R., Collins, K. et al. (3 more authors) (2018) Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems. BMC Cancer, 18 (1). 667.

Abstract

Metadata

Authors/Creators:
  • Greasley, R.U.
  • Turner, R.
  • Collins, K.
  • Brown, J.
  • Bourke, L.
  • Rosario, D.J.
Copyright, Publisher and Additional Information: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dates:
  • Published: 19 June 2018
  • Accepted: 18 May 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 06 Jul 2018 15:54
Last Modified: 06 Jul 2018 15:54
Published Version: https://doi.org/10.1186/s12885-018-4527-y
Status: Published online
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s12885-018-4527-y
Related URLs:

Share / Export

Statistics